Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Interest Expenses (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Interest Expenses data on record, last reported at $842000.0 in Q4 2024.

  • For Q4 2024, Interest Expenses fell 74.01% year-over-year to $842000.0; the TTM value through May 2025 reached $5.2 million, down 64.25%, while the annual FY2024 figure was $14.7 million, 14.9% down from the prior year.
  • Interest Expenses reached $842000.0 in Q4 2024 per LFCR's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $10.4 million in Q2 2023 and bottomed at -$13.6 million in Q2 2022.
  • Average Interest Expenses over 5 years is $2.7 million, with a median of $3.2 million recorded in 2022.
  • Peak YoY movement for Interest Expenses: skyrocketed 301.08% in 2021, then plummeted 535.69% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $1.6 million in 2020, then soared by 73.37% to $2.8 million in 2021, then soared by 30.39% to $3.6 million in 2022, then decreased by 10.2% to $3.2 million in 2023, then plummeted by 74.01% to $842000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $842000.0 in Q4 2024, $4.4 million in Q3 2024, and $4.9 million in Q2 2024.